{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:28:03Z","timestamp":1794360483422,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004360","name":"Swedish University of Agricultural Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tvjl.2026.106867","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:06:41Z","timestamp":1788538001000},"page":"106867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Blood pressure, electrolyte and fluid balance in horses with insulin dysregulation after short-term treatment with canagliflozin"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-8397","authenticated-orcid":false,"given":"Katarina","family":"Nostell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Lind\u00e5se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Svonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-0420","authenticated-orcid":false,"given":"Katja","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-6365","authenticated-orcid":false,"given":"Johan","family":"Br\u00f6jer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106867_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tvjl.2007.07.003","article-title":"Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies","volume":"174","author":"Asplin","year":"2007","journal-title":"The Vet. J."},{"key":"10.1016\/j.tvjl.2026.106867_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2460\/ajvr.69.1.122","article-title":"Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis","volume":"69","author":"Bailey","year":"2008","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tvjl.2026.106867_bib3","article-title":"Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes","volume":"33","author":"Benham","year":"2021","journal-title":"Int. J. Cardiology Heart and Vasculature"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106867_bib4","first-page":"A288","article-title":"Canagliflozin (CANA) lowers A1C and blood pressure (BP) through weight loss-independent (WL-I) and weight loss-associated (WL-A) mechanisms","volume":"62","author":"Blonde","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tvjl.2026.106867_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1939-1676.2007.tb03005.x","article-title":"Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2026.106867_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin on renal handling of sodium potassium, calcium and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tvjl.2026.106867_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jvim.15423","article-title":"ECEIM consensus statement on equine metabolic syndrome","volume":"2","author":"Durham","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2026.106867_bib8","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/dom.13413","article-title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3a): The derive study","volume":"20","author":"Fioretto","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tvjl.2026.106867_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in heart failure: diuretic and cardiorenal effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2026.106867_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2460\/javma.250.9.1027","article-title":"Cardiovascular findings in ponies with equine metabolic syndrome","volume":"250","author":"Heliczer","year":"2017","journal-title":"Am. J. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2026.106867_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","article-title":"Sodium glucose Co-Transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology","volume":"5","author":"Kalra","year":"2014","journal-title":"Diabetes. Ther."},{"key":"10.1016\/j.tvjl.2026.106867_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5455\/OVJ.2022.v12.i4.14","article-title":"Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis","volume":"12","author":"Kellon","year":"2022","journal-title":"Open. Vet. J."},{"key":"10.1016\/j.tvjl.2026.106867_bib13","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1172\/JCI114644","article-title":"Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance","volume":"85","author":"Laakso","year":"1990","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.tvjl.2026.106867_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13028-016-0246-z","article-title":"A modified oral sugar test for evaluation of insulin and glucose dynamics in horses","volume":"20","author":"Lind\u00e5se","year":"2016","journal-title":"ACTA Vet. Scand."},{"key":"10.1016\/j.tvjl.2026.106867_bib15","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/jvim.16906","article-title":"Short-term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo-controlled, double-blind, study","volume":"37","author":"Lindase","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2026.106867_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12917-019-1811-2","article-title":"The efficacy and safety of velagliflozin over 16\u2009weeks as a treatment for insulin dysregulation in ponies","volume":"15","author":"Meier","year":"2019","journal-title":"BMC. Vet. Res."},{"key":"10.1016\/j.tvjl.2026.106867_bib17","article-title":"Vascular dysfunction in horses with endocrinopathiclaminitis. PLoSOne","volume":"11","author":"Morgan","year":"2016"},{"key":"10.1016\/j.tvjl.2026.106867_bib18","first-page":"737","article-title":"The effect of insulin infusion on heart rate and systemic blood pressure in horses with equine metabolic syndrome","author":"Nostell","year":"2019","journal-title":"Equine Vet. J. 51,733 -"},{"key":"10.1016\/j.tvjl.2026.106867_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/vec.12411","article-title":"Accuracy and precision of oscillometric blood pressure in standing conscious horses","volume":"26","author":"Olsen","year":"2016","journal-title":"Vet. Emerg. Crit. Care"},{"key":"10.1016\/j.tvjl.2026.106867_bib20","doi-asserted-by":"crossref","first-page":"E867","DOI":"10.1210\/jc.2012-4205","article-title":"Validation of a novel method for determining the renal threshold for glucose excretion in untreated and canagliflozin-treated subjects with type 2 diabetes mellitus","volume":"98","author":"Polidori","year":"2013","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"10.1016\/j.tvjl.2026.106867_bib21","first-page":"1","article-title":"Sodium-glucose cotransporter inhibition benefits in cardiorenal risk in men and women","volume":"7","author":"Pruett","year":"2023","journal-title":"J. End. Society."},{"key":"10.1016\/j.tvjl.2026.106867_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76256-6","article-title":"Model based meta-analysis of HbA1c reduction across SGLT2 inhibitors using a dose adjusted by urinary excretion","volume":"14","author":"Sato","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvjl.2026.106867_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/dom.12322","article-title":"Effect of the sodium glucose co-transporter 2 inhibitor, canagliflozin, on plasma volume in patients with type 2 diabetes mellitus","author":"Sha","year":"2014","journal-title":"Diabetes Obesity and Metabolism16"},{"key":"10.1016\/j.tvjl.2026.106867_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/eve.13738","article-title":"Preliminary observations on the use of ertugliflozin in the management of hyperinsulinemia and laminitis in 51 horses: a case series","volume":"35","author":"Sundra","year":"2022","journal-title":"Equine Vet. Education."},{"key":"10.1016\/j.tvjl.2026.106867_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/eve.13738","article-title":"Preliminary observations on the use of ertugliflozin in the management of hyperinsulinaemia and laminitis in 51 horses: a case series","volume":"35","author":"Sundra","year":"2023","journal-title":"Equine Vet. Educ."},{"key":"10.1016\/j.tvjl.2026.106867_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1751-0147-54-37","article-title":"Interday variation and effect of transportation on indirect blood pressure measurements, plasma endothelin-1 and serum cortisol in Standardbred and Icelandic horses","volume":"54","author":"S\u00f6der","year":"2012","journal-title":"Acta. Vet. Scand."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106867_bib27","article-title":"Effects of Sodium\/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials","volume":"10","author":"Teo","year":"2021","journal-title":"J. Am. Heart Assoc. 24"},{"key":"10.1016\/j.tvjl.2026.106867_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/vaa.12203","article-title":"Agreement of high definition oscillometry with direct arterial blood pressure measurement at different blood pressure ranges in horses under general anaesthesia","volume":"42","author":"T\u00fcnsmeyer","year":"2015","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.tvjl.2026.106867_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0038-1623201","article-title":"Noninvasive blood pressure measurement using high definition oscillometry in horses with heart diseases","volume":"421","author":"Walders","year":"2014","journal-title":"Tierarztl. Praxis Ausgabe Giornale Grosstiere\/Nutztiere"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106867_bib30","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.21037\/apm-21-1022","article-title":"The effects of sodium glucose co-transporter (SGLT) 2 inhibitors on hematocrit levels: a systematic review and meta-analysis of randomized controlled trial","volume":"10","author":"Wang","year":"2021","journal-title":"Ann Palliat Med."},{"key":"10.1016\/j.tvjl.2026.106867_bib31","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1185\/03007995.2014.919907","article-title":"Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate","volume":"30","author":"Weir","year":"2014","journal-title":"Cur Med. Res. Opinion"},{"key":"10.1016\/j.tvjl.2026.106867_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12933-022-01676-5","article-title":"Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease","volume":"21","author":"Zhang","year":"2022","journal-title":"Cardiovasc. Diabetol."}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:17:43Z","timestamp":1794359863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326003242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S1090023326003242"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106867","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure, electrolyte and fluid balance in horses with insulin dysregulation after short-term treatment with canagliflozin","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106867"}}